274 related articles for article (PubMed ID: 16564763)
21. Progress in prevention: the COURAGE of our convictions.
Hughes S; Hayman LL
J Cardiovasc Nurs; 2007; 22(4):259-60. PubMed ID: 17589275
[No Abstract] [Full Text] [Related]
22. Effects of urate-lowering therapy in hyperuricemia on slowing the progression of renal function: a meta-analysis.
Wang H; Wei Y; Kong X; Xu D
J Ren Nutr; 2013 Sep; 23(5):389-96. PubMed ID: 23131573
[TBL] [Abstract][Full Text] [Related]
23. Uricosuric activity of suxibuzone, a new phenylbutazone derivative.
Erill S; Laporte J
Arch Farmacol Toxicol; 1975 Mar; 1(1):43-6. PubMed ID: 1231648
[No Abstract] [Full Text] [Related]
24. [The Anturan reinfarct study].
Sherry S
Wien Med Wochenschr Suppl; 1980; 61():17-22. PubMed ID: 6930766
[No Abstract] [Full Text] [Related]
25. [When and how to treat hyperuricemia].
Rubens-Duval A
Therapeutique; 1973 Apr; 49(4):263-5. PubMed ID: 4775219
[No Abstract] [Full Text] [Related]
26. Uric acid lowering improves insulin sensitivity and lowers blood pressure: a meta-analysis of randomized parallel-controlled clinical trials.
Zong Q; Ma G; Wang T
Afr Health Sci; 2021 Mar; 21(1):82-95. PubMed ID: 34394285
[TBL] [Abstract][Full Text] [Related]
27. The clinical significance of hyperuricemia.
Seegmiller JE
Med Ann Dist Columbia; 1967 Apr; 36(4):215-8. PubMed ID: 5232849
[No Abstract] [Full Text] [Related]
28. Assessment of outcome in clinical trials of gout--a review of current measures.
Taylor WJ; Schumacher HR; Singh JA; Grainger R; Dalbeth N
Rheumatology (Oxford); 2007 Dec; 46(12):1751-6. PubMed ID: 17650521
[TBL] [Abstract][Full Text] [Related]
29. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
[TBL] [Abstract][Full Text] [Related]
30. Translational therapeutics at the platelet vascular interface. Summary.
FitzGerald GA
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s51-2. PubMed ID: 18296588
[No Abstract] [Full Text] [Related]
31. [Is hyperuricemia a cardiovascular risk factor?].
Chizyński K; Rózycka M
Wiad Lek; 2006; 59(5-6):364-7. PubMed ID: 17017483
[TBL] [Abstract][Full Text] [Related]
32. [The platelet inhibitor problem].
Straub PW
Schweiz Med Wochenschr; 1981 Apr; 111(14):478-82. PubMed ID: 7015489
[TBL] [Abstract][Full Text] [Related]
33. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial.
Anturane Reinfarction Trial Research Group
N Engl J Med; 1978 Feb; 298(6):289-95. PubMed ID: 340942
[TBL] [Abstract][Full Text] [Related]
34. [Benziodarone therapy in hyperuricemia in the aged].
Ravera M; Ugo C
G Gerontol; 1970 Sep; 18(9):876-9. PubMed ID: 5517231
[No Abstract] [Full Text] [Related]
35. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial.
Baker JF; Schumacher HR; Krishnan E
Angiology; 2007; 58(4):450-7. PubMed ID: 17875958
[TBL] [Abstract][Full Text] [Related]
36. Long-term cardiovascular mortality among middle-aged men with gout.
Krishnan E; Svendsen K; Neaton JD; Grandits G; Kuller LH;
Arch Intern Med; 2008 May; 168(10):1104-10. PubMed ID: 18504339
[TBL] [Abstract][Full Text] [Related]
37. Serum uric acid: a risk factor and a target for treatment?
Feig DI; Mazzali M; Kang DH; Nakagawa T; Price K; Kannelis J; Johnson RJ
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S69-73. PubMed ID: 16565251
[TBL] [Abstract][Full Text] [Related]
38. [Clinical course and management of asymptomatic hyperuricemia].
Nishida Y
Nihon Rinsho; 1991 May; 49(5):1086-92. PubMed ID: 2067099
[No Abstract] [Full Text] [Related]
39. [Letter: Hyperuricemia].
Mertz DP
Dtsch Med Wochenschr; 1974 Aug; 99(32):1637. PubMed ID: 4843517
[No Abstract] [Full Text] [Related]
40. [Treatment of hyperuricemia with benziodarone].
Ravault PP; Vignon G; Lejeune E; Bouvier M; Queneau P
Presse Therm Clim; 1970; 107(2):74-9. PubMed ID: 5468122
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
